PL3358355T3 - Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób - Google Patents
Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych choróbInfo
- Publication number
- PL3358355T3 PL3358355T3 PL17461508.8T PL17461508T PL3358355T3 PL 3358355 T3 PL3358355 T3 PL 3358355T3 PL 17461508 T PL17461508 T PL 17461508T PL 3358355 T3 PL3358355 T3 PL 3358355T3
- Authority
- PL
- Poland
- Prior art keywords
- diseases
- prdx
- adpkd
- igan
- ckd
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 2
- 208000010061 Autosomal Dominant Polycystic Kidney Diseases 0.000 title 1
- 208000010159 IgA glomerulonephritis Diseases 0.000 title 1
- 206010021263 IgA nephropathy Diseases 0.000 title 1
- 208000005777 Lupus Nephritis Diseases 0.000 title 1
- 102000007456 Peroxiredoxin Human genes 0.000 title 1
- 208000022185 autosomal dominant polycystic kidney disease Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 208000020832 chronic kidney disease Diseases 0.000 title 1
- 230000004069 differentiation Effects 0.000 title 1
- 108030002458 peroxiredoxin Proteins 0.000 title 1
- 210000002966 serum Anatomy 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/902—Oxidoreductases (1.)
- G01N2333/908—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/34—Genitourinary disorders
- G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17461508.8A EP3358355B1 (en) | 2017-02-04 | 2017-02-04 | Use of serum 2-cysteine peroxiredoxins (2-cys-prdx) as biomarkers of chronic kidney diseases (ckd) such as lupus nephritis (ln), iga nephropathy (igan) and autosomal-dominant polycystic kidney disease (adpkd) useful for diagnosing, these diseases and method of differentiation of these diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3358355T3 true PL3358355T3 (pl) | 2024-04-08 |
Family
ID=57984871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17461508.8T PL3358355T3 (pl) | 2017-02-04 | 2017-02-04 | Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200064344A1 (pl) |
| EP (1) | EP3358355B1 (pl) |
| AU (1) | AU2018215249A1 (pl) |
| CA (1) | CA3052545A1 (pl) |
| IL (1) | IL268477A (pl) |
| PL (1) | PL3358355T3 (pl) |
| WO (1) | WO2018141975A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102403211B1 (ko) * | 2020-08-21 | 2022-05-27 | 중앙대학교 산학협력단 | 퍼옥시레독신 4를 이용한 포유동물의 산자수 예측용 조성물 |
| CN117491636A (zh) * | 2023-11-21 | 2024-02-02 | 郑州大学 | 一种用于肺癌诊断的生物标志物及其应用 |
| CN118962136B (zh) * | 2024-10-17 | 2024-12-13 | 中南大学湘雅二医院 | Prdx2作为生物标志物在急性肾损伤辅助诊断和预后预测中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1360965A4 (en) | 2001-02-16 | 2009-07-29 | Asubio Pharma Co Ltd | METHOD FOR THE TREATMENT OF DISEASES ASSOCIATED WITH A DECREASE OF THE EXPOSURE OF THE AOP-1 GENE OR AOP-1 AND MEANS FOR THE TREATMENT OF THE DISEASES |
| WO2005116082A1 (en) | 2004-05-27 | 2005-12-08 | Industry-Academic Cooperation Foundation Gyeong Sang National University | 2-cysteine peroxiredoxin complex exhibiting function acting as molecular chaperone and uses thereof |
| WO2009151511A1 (en) | 2008-04-29 | 2009-12-17 | Therasis, Inc. | Systems and methods for identifying combinations of compounds of therapeutic interest |
| KR100928403B1 (ko) | 2008-10-01 | 2009-11-26 | 경북대학교 산학협력단 | 티지비엠 신증의 진단용 조성물 및 키트 |
| WO2010099477A2 (en) | 2009-02-27 | 2010-09-02 | Atyr Pharma, Inc. | Polypeptide structural motifs associated with cell signaling activity |
| WO2011081229A1 (ko) | 2009-12-29 | 2011-07-07 | 이화여자대학교 산학협력단 | 혈관신생 억제용 약제학적 조성물 |
| US20130040833A1 (en) | 2010-05-12 | 2013-02-14 | The General Hospital Corporation | Use of microvesicles in analyzing nucleic acid profiles |
| US20130210667A1 (en) | 2010-09-10 | 2013-08-15 | The Ohio State University | Biomarkers for Predicting Kidney and Glomerular Pathologies |
| EP3151012B1 (en) * | 2010-09-21 | 2018-03-21 | Proteomics International Pty Ltd | Biomarkers associated with diabetic nephropathy |
| US20140038203A1 (en) * | 2012-07-09 | 2014-02-06 | Musc Foundation For Research Development | Methods for detecting or predicting kidney disease |
| US20140221325A1 (en) * | 2013-02-01 | 2014-08-07 | Meso Scale Technologies, Llc | Glomerulonephritis biomarkers |
| HK1248804A1 (zh) | 2015-03-30 | 2018-10-19 | Hycor生物医学有限责任公司 | 用於执行自身免疫性疾病和感染性疾病的诊断性测定的自动化的免疫分析仪系统 |
-
2017
- 2017-02-04 PL PL17461508.8T patent/PL3358355T3/pl unknown
- 2017-02-04 EP EP17461508.8A patent/EP3358355B1/en active Active
-
2018
- 2018-02-05 AU AU2018215249A patent/AU2018215249A1/en not_active Abandoned
- 2018-02-05 WO PCT/EP2018/052837 patent/WO2018141975A1/en not_active Ceased
- 2018-02-05 US US16/483,251 patent/US20200064344A1/en not_active Abandoned
- 2018-02-05 CA CA3052545A patent/CA3052545A1/en not_active Abandoned
-
2019
- 2019-08-04 IL IL268477A patent/IL268477A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018215249A1 (en) | 2019-08-22 |
| EP3358355B1 (en) | 2023-10-11 |
| WO2018141975A1 (en) | 2018-08-09 |
| US20200064344A1 (en) | 2020-02-27 |
| EP3358355A1 (en) | 2018-08-08 |
| IL268477A (en) | 2019-09-26 |
| CA3052545A1 (en) | 2018-08-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3734395A4 (en) | METHOD OF SWITCHING THE OPERATING MODE OF A CARDAN SUSPENSION AND CONTROL AND IMAGE STABILITY ENHANCEMENT DEVICE | |
| EP3221835A4 (en) | Model-based prediction of an optimal convenience metric for authorizing transactions | |
| EP3161481A4 (en) | System for assessing global wellness | |
| EP3463617A4 (en) | METHOD FOR DETERMINING THE CAPACITY USED TO USE AN AIR FILTER | |
| EP3113684A4 (en) | Method and system for assessing motion symptoms | |
| EP3512539A4 (en) | METHODS FOR TREATING LUNG DISEASE USING INTER-ALPHA INHIBITOR PROTEINS | |
| IL257146A (en) | A method for reducing host cell proteins in affinity chromatography | |
| EP3234698A4 (en) | Positional control features between replaceable units of an electrophotographic image forming device | |
| PL3358355T3 (pl) | Zastosowanie surowiczych peroksyredoksyn dwucysteinowych (2-Cys-PRDX) jako biomarkerów przewlekłej choroby nerek (PChN, ang. CKD) takiej jak toczniowe zapalenie nerek (LN), nefropatia IgA (IgAN) i autosomalna dominująca wielotorbielowatość nerek (ADPKD) użytecznych do diagnozowania tych chorób i sposoby różnicowania tych chorób | |
| EP3538893A4 (en) | PROCESSES FOR IDENTIFYING CANDIDATE BIOMARKERS | |
| EP3528824A4 (en) | METHOD FOR PREDICTING THE TRANSPLANT-HOST REACTION | |
| EP3204516A4 (en) | Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response | |
| EP3191629A4 (en) | Peptide microarrays and novel biomarkers for celiac disease | |
| PL3152330T3 (pl) | SPOSOBY DIAGNOZOWANIA PRZEWLEKŁEJ OBTURACYJNEJ CHOROBY PŁUC (POChP) Z ZASTOSOWANIEM NOWYCH BIOMARKERÓW MOLEKULARNYCH | |
| EP3535584A4 (en) | IMMUNOASSAY SYSTEM FOR RECOMMENDING TESTS BASED ON INPUT DATA | |
| EP3258927B8 (en) | Host defense protein (hdp) mimetics for prophylaxis and/or treatment of inflammatory diseases of the gastrointestinal tract | |
| PL3235666T3 (pl) | Miech na przejściu pomiędzy dwoma pojazdami połączonymi przegubowo | |
| EP3807077A4 (en) | Evaluating candidate virtual build volumes | |
| EP3695224A4 (en) | Prognosis and progression biomarkers for chronic kidney disease | |
| EP3112867A4 (en) | Qualitative predictive method for differential diagnosis of pneumococcic, meningococcic and viral menigitis, differential meningitis diagnostic method and kit | |
| EP3894581A4 (en) | NUCLEIC ACID BIOMARKERS FOR PLACENTAL DYSFUNCTION | |
| EP3400441A4 (en) | SIGNATURES OF BIOMARKERS FOR THE DIFFERENTIATION OF LYME DISEASE AND METHODS OF USE THEREOF | |
| PL3337817T3 (pl) | Sposób zmniejszania zawartości białek komórek gospodarza w chromatografii powinowactwa | |
| HK1250176A1 (zh) | 用於确定细胞疗法的临床反应的生物标志物 | |
| EP3323828A4 (en) | ANTIBODIES FOR DETERMINING THE SEX OF SPERMA AND USE THEREOF |